Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23577 | 23663110 | J Gastroenterol Hepatol | Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease. | 2013 | Details |
| A23578 | 23661906 | Mediators Inflamm | Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD. | 2013 | Details |
| A23579 | 23660937 | Eur J Gastroenterol Hepatol | Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography. | 2013 | Details |
| A23580 | 23659066 | Klin Med (Mosk) | [Low and very low density lipoproteins: pathogenetic and clinical significance]. | 2013 | Details |
| A23581 | 23658732 | PLoS One | The absence of obstructive sleep apnea may protect against non-alcoholic fatty liver in patients undergoing bariatric surgery. | 2013 | Details |
| A23582 | 23657989 | Intern Emerg Med | Physical activity for the prevention and treatment of metabolic disorders. | 2013 | Details |
| A23583 | 23657151 | Curr Opin Clin Nutr Metab Care | Carbohydrate intake and nonalcoholic fatty liver disease. | 2013 | Details |
| A23584 | 23656726 | Br J Nutr | Effects of long-term administration of saturated and n-3 fatty acid-rich diets on lipid utilisation and oxidative stress in rat liver and muscle tissues. | 2013 | Details |
| A23586 | 23656177 | Liver Int | Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up. | 2013 | Details |
| A23587 | 23654092 | Wei Sheng Yan Jiu | [Effects of Chinese wild rice on lipid metabolism and lipotoxicity in rats fed with high fat/cholesterol diet]. | 2013 | Details |
| A23588 | 23653642 | Int J Endocrinol | Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. | 2013 | Details |
| A23589 | 23653455 | Eur J Endocrinol | Non-alcoholic fatty liver disease in common endocrine disorders. | 2013 | Details |
| A23590 | 23653231 | Mol Nutr Food Res | Effects of raftilose on serum biochemistry and liver morphology in rats fed with normal or high-fat diet. | 2013 | Details |
| A23591 | 23652610 | Curr Opin Organ Transplant | Evolving aspects of liver transplantation for nonalcoholic steatohepatitis. | 2013 | Details |
| A23593 | 23651850 | Am J Physiol Endocrinol Metab | Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways. | 2013 | Details |
| A23594 | 23651847 | Am J Physiol Endocrinol Metab | Exercise training improves cutaneous microvascular function in nonalcoholic fatty liver disease. | 2013 | Details |
| A23595 | 23651738 | Toxicol Appl Pharmacol | Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction. | 2013 | Details |
| A23596 | 23647015 | Br J Pharmacol | Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats. | 2013 | Details |
| A23597 | 23643483 | Toxicol Lett | Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease. | 2013 | Details |
| A23598 | 23643404 | Metabolism | Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey. | 2013 | Details |
| A23599 | 23642511 | Am J Cardiol | Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease. | 2013 | Details |
| A23600 | 23641933 | BMC Infect Dis | Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors. | 2013 | Details |
| A23601 | 23638085 | PLoS One | Novel algorithm for non-invasive assessment of fibrosis in NAFLD. | 2013 | Details |
| A23602 | 23636881 | J Gastrointest Surg | Cadmium exposure and liver disease among US adults. | 2013 | Details |
| A23603 | 23634883 | Lipids Health Dis | Flaxseed oil and alpha-lipoic acid combination ameliorates hepatic oxidative stress and lipid accumulation in comparison to lard. | 2013 | Details |
| A23604 | 23634670 | Diabetes Technol Ther | Obesity and diabetes: newer concepts in imaging. | 2013 | Details |
| A23606 | 23633195 | J Clin Endocrinol Metab | Association of glypican-4 with body fat distribution, insulin resistance, and nonalcoholic fatty liver disease. | 2013 | Details |
| A23607 | 23630437 | Int J Med Sci | Status of essential trace minerals and oxidative stress in viral hepatitis C patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A23609 | 23627940 | Curr Med Chem | Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus. | 2013 | Details |
| A23610 | 23627434 | Clin Sci (Lond) | Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients. | 2013 | Details |
| A23611 | 23627007 | Crit Rev Immunol | Role of scavenger receptors in the pathophysiology of chronic liver diseases. | 2013 | Details |
| A23612 | 27904876 | Postdoc J | The Mediation of Hepatic Lipogenesis Through Estrogens. | 2013 | Details |
| A23613 | 23626730 | PLoS One | Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability. | 2013 | Details |
| A23614 | 23626003 | J Clin Endocrinol Metab | Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage. | 2013 | Details |
| A23615 | 23625798 | Pediatr Obes | Calorie-sweetened beverages and fructose: what have we learned 10 years later. | 2013 | Details |
| A23616 | 23625197 | Curr Diab Rep | The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus. | 2013 | Details |
| A23617 | 23624251 | J Hepatol | Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance. | 2013 | Details |
| A23618 | 23623999 | J Hepatol | PTEN protein phosphatase activity regulates hepatitis C virus secretion through modulation of cholesterol metabolism. | 2013 | Details |
| A23619 | 23623998 | J Hepatol | Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. | 2013 | Details |
| A23620 | 23623710 | Rev Med Interne | [Unexplained, subclinical chronically elevated transaminases]. | 2013 | Details |
| A23621 | 23622654 | Transplant Proc | Recurrence of disease after liver transplantation. | 2013 | Details |
| A23623 | 23619824 | Cell Biol Int | Correlation analysis between gene expression profile of high-fat emulsion-induced non-alcoholic fatty liver and liver regeneration in rat. | 2013 | Details |
| A23624 | 23619258 | Ann Hepatol | Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population. | 2013 | Details |
| A23625 | 23619251 | Ann Hepatol | Probiotics in non-alcoholic fatty liver disease: which and when. | 2013 | Details |
| A23626 | 23619181 | Ther Umsch | [Not Available]. | 2013 | Details |
| A23627 | 23618531 | J Nutr Biochem | Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice. | 2013 | Details |
| A23628 | 23617326 | Hepatol Res | Visceral fat predominance is associated with non-alcoholic fatty liver disease in Japanese women with metabolic syndrome. | 2013 | Details |
| A23629 | 23616151 | J Clin Endocrinol Metab | Improved hepatic lipid composition following short-term exercise in nonalcoholic fatty liver disease. | 2013 | Details |
| A23630 | 23613622 | World J Gastroenterol | Dipeptidyl peptidase-4: a key player in chronic liver disease. | 2013 | Details |
| A23631 | 23612512 | Eur J Clin Nutr | Overweight, obesity and related non-communicable diseases in Asian Indian girls and women. | 2013 | Details |
| A23632 | 23611286 | Adv Immunol | The intestinal microbiota in chronic liver disease. | 2013 | Details |
| A23633 | 23611112 | Clin Exp Pharmacol Physiol | A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice. | 2013 | Details |
| A23634 | 23609794 | Dig Dis Sci | Functional impairment in alcoholic liver disease and non-alcoholic fatty liver disease is significant and persists over 3 years of follow-up. | 2013 | Details |
| A23635 | 23609339 | Ultrasound Q | Sonographic evaluation for predicting the presence and severity of coronary artery disease. | 2013 | Details |
| A23636 | 23607402 | Hepatol Res | Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride-induced liver fibrosis. | 2013 | Details |
| A23637 | 23607320 | Hepatol Res | Liver damage is not reversed during the lean period in diet-induced weight cycling in mice. | 2013 | Details |
| A23638 | 23607264 | Hepatol Res | Efficacy of probucol for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label pilot study. | 2013 | Details |
| A23639 | 23605066 | Pflugers Arch | Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation. | 2013 | Details |
| A23640 | 23603008 | Food Chem Toxicol | Taraxacum official (dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver. | 2013 | Details |
| A23641 | 23603006 | Food Chem Toxicol | Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. | 2013 | Details |
| A23642 | 23602473 | Arch Med Res | Relationship between visceral adipose tissue and adiponectin, inflammatory markers and thyroid hormones in obese males with hepatosteatosis and insulin resistance. | 2013 | Details |
| A23643 | 23601769 | Clin Imaging | Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease. | 2012 | Details |
| A23644 | 23601740 | Med Clin (Barc) | [Risk factors associated with non-alcoholic fatty liver disease: a case-control study]. | 2013 | Details |
| A23645 | 23600632 | Metab Syndr Relat Disord | Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography. | 2013 | Details |
| A23646 | 23600493 | Expert Opin Ther Targets | Novel therapeutic targets for nonalcoholic fatty liver disease. | 2013 | Details |
| A23647 | 23600144 | Yao Xue Xue Bao | [Effects of pomegranate flowers polyphenols on liver PON expression of diabetes combining non-alcoholic fat liver diseases rats]. | 2013 | Details |
| A23648 | 23598120 | Talanta | Validated liquid chromatography-tandem mass spectrometry method for determination of totally nine probe metabolites of cytochrome P450 enzymes and UDP-glucuronosyltransferases. | 2012 | Details |
| A23649 | 23597944 | Ann Endocrinol (Paris) | Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: which clinical arguments? | 2013 | Details |
| A23650 | 23597924 | Med Mal Infect | Liver stiffness values in HIV-infected patients with isolated anti-hepatitis B core antibodies. | 2013 | Details |
| A23651 | 23597726 | Gastroenterology | Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. | 2013 | Details |
| A23652 | 23596966 | Clin Sci (Lond) | Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. | 2013 | Details |
| A23653 | 23596266 | Asia Pac J Public Health | The clinical investigation of disparity of nonalcoholic fatty liver disease in a Chinese occupational population in Taipei, Taiwan: experience at a teaching hospital. | 2013 | Details |
| A23654 | 23594995 | Int J Mol Sci | Dual role of microRNAs in NAFLD. | 2013 | Details |
| A23655 | 23594525 | Hum Hered | Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity. | 2013 | Details |
| A23656 | 23593497 | PLoS One | Neuroendocrine regulation and metabolism of glucose and lipids in primary chronic insomnia: a prospective case-control study. | 2013 | Details |
| A23657 | 23592668 | Obesity (Silver Spring) | Nonalcoholic fatty liver disease in severely obese adolescent and adult patients. | 2013 | Details |
| A23658 | 23592667 | Obesity (Silver Spring) | Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children. | 2013 | Details |
| A23659 | 23592516 | Mol Pharmacol | Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model. | 2013 | Details |
| A23660 | 23589141 | Dig Dis Sci | No significant association between vitamin D and nonalcoholic fatty liver disease in a Chinese population. | 2013 | Details |
| A23661 | 23588628 | Tunis Med | [Non alcoholic fatty liver disease: a new risk factor for cardiovascular disease?]. | 2013 | Details |
| A23662 | 23588583 | Eur Radiol | Liver fat volume fraction quantification with fat and water T1 and T 2* estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T. | 2013 | Details |
| A23663 | 23587889 | Br J Nurs | Clinical trial: physical, psychological and social needs of patients. | 2013 | Details |
| A23664 | 23586841 | Eur J Clin Invest | Activated complement factor 3 is associated with liver fat and liver enzymes: the CODAM study. | 2013 | Details |
| A23665 | 23585904 | PLoS One | Fructus Xanthii attenuates hepatic steatosis in rats fed on high-fat diet. | 2013 | Details |
| A23666 | 23584921 | High Blood Press Cardiovasc Prev | Non-alcoholic fatty liver disease is not associated with vitamin D deficiency in essential hypertension. | 2013 | Details |
| A23667 | 23583988 | Intern Med | An increased circulating angiotensin II concentration is associated with hypoadiponectinemia and postprandial hyperglycemia in men with nonalcoholic fatty liver disease. | 2013 | Details |
| A23669 | 23582557 | Rev Assoc Med Bras (1992) | [Nonalcoholic fatty liver disease and its association with metabolic syndrome in the preoperative period in patients undergoing bariatric surgery]. | 2013 | Details |
| A23670 | 23578884 | J Hepatol | Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. | 2013 | Details |
| A23672 | 23578506 | Zhonghua Yi Xue Za Zhi | [Liver disease spectrum in hospitalized type 2 diabetes and related risk factors analysis of non-alcoholic fatty liver disease]. | 2013 | Details |
| A23673 | 23577962 | J Gastroenterol Hepatol | Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle. | 2013 | Details |
| A23674 | 23576902 | ScientificWorldJournal | Current concepts and management approaches in nonalcoholic fatty liver disease. | 2013 | Details |
| A23675 | 23576797 | Exp Biol Med (Maywood) | Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease. | 2013 | Details |
| A23676 | 23573117 | Evid Based Complement Alternat Med | Qushi Huayu Decoction Inhibits Hepatic Lipid Accumulation by Activating AMP-Activated Protein Kinase In Vivo and In Vitro. | 2013 | Details |
| A23677 | 23569998 | Asian Pac J Trop Biomed | Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease. | 2012 | Details |
| A23678 | 23568965 | J Physiol Pharmacol | Is fatty liver always benign and should not consequently be treated? | 2013 | Details |
| A23680 | 23567356 | Am J Gastroenterol | Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study. | 2013 | Details |
| A23681 | 23567086 | J Hepatol | Decoding cell death signals in liver inflammation. | 2013 | Details |
| A23682 | 23567085 | J Hepatol | Cannabinoid signaling and liver therapeutics. | 2013 | Details |
| A23683 | 23567080 | J Hepatol | Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression. | 2013 | Details |
| A23684 | 23565851 | Expert Opin Drug Metab Toxicol | Role of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease. | 2013 | Details |